This led to the hypothesis that variants in BARD1 could encode an aberrant protein affecting the interaction with BRCA1 and predispose to BC and/or OC, especially in hereditary cancer syndrome families not accounted for by BRCA1 or BRCA2 [6]. This evidence concerns the gene BRCA1 and breast cancer.